Table 2.
Indispensable amino acid | Rat study | Human study | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
RQ | Sex | NOAEL | LOAEL | NOAEL/RQ | LOAEL/RQ | RQ | Sex | NOAEL | LOAEL | NOAEL/RQ | LOAEL/RQ | |
mg/kg BW/day | mg/kg BW/day | |||||||||||
L-Histidine | 133.3 | M | 1631 | 3481 | 12.2 | 26.1 | 11.0 | F | 91.2 | 134.1 | 8.3 | 12.2 |
F | 1757 | 3592 | 13.2 | 26.9 | ||||||||
L-Isoleucine | 295.2 | M | 1565 | 3008 | 5.3 | 10.2 | 15.0 | NI | ND | ND | ND | ND |
F | 1646 | 3702 | 5.6 | 12.5 | ||||||||
L-Leucine | 509.5 | M | 3333 | ND | 6.5 | ND | 34.0 | M | 500.0 | ND | 14.7 | ND |
F | 3835 | ND | 7.5 | ND | ||||||||
L-Lysine | 438.1 | M | 3357 | ND | 7.7 | ND | 31.0 | M | 85.7 | 107.1 | 2.8 | 3.5 |
F | 3986 | ND | 9.1 | ND | ||||||||
L-Methionine | 309.5 | M | 630 | 1100 | 2.0 | 3.6 | 10.1 | F/M (9/6) | 46.3 | 91.0 | 4.6 | 9.0 |
F | ND | ND | ND | ND | ||||||||
L-Phenylalanine | 323.8 | M | 1548 | 4903 | 4.8 | 15.1 | 27.0* | M | 169.3 | ND | 6.3 | ND |
F | 1555 | 4701 | 4.8 | 14.5 | ||||||||
L-Threonine | 295.2 | M | 3267 | ND | 11.1 | ND | 16.0 | NI | ND | ND | ND | ND |
F | 3673 | ND | 12.4 | ND | ||||||||
L-Tryptophan | 95.2 | M | 948 | 1735 | 10.0 | 18.2 | 4.0 | F | 98.4 | ND | 24.6 | ND |
F | 1956 | 3705 | 20.5 | 38.9 | ||||||||
L-Valine | 352.4 | M | 3225 | ND | 9.2 | ND | 19.0 | NI | ND | ND | ND | ND |
F | 1853 | 3721 | 5.3 | 10.6 |
RQ is the value of requirement. In rats, RQ is amino acid requirements for growing rats (Benevenga et al. 1994). NOAEL is the No Observed Adverse Effect Level. LOAEL is the Lowest Observed Adverse Effect Level. F and M indicate experiments performed with female and male rats, and women and men, respectively. ND means not determined. NI means not indicated. The data indicated in bold allow rapid comparison of the ratio calculated in rats and humans when available
*RQ of phenylalanine/tyrosine